Yes, I know everyone is ready to pop the champagne and celebrate a great milestone in GBIF’s history, and deservedly so, but I hope I’m not the only one wondering on the broader implications. Given the publicity that will surround this milestone, I think this is exactly the time to be thinking and talking about “what’s next”. I’ve sketched some thoughts on iPhylo http://iphylo.blogspot.com/2018/07/gbif-at-1-billion-what-next.html and on Twitter. I guess I’m looking for a little visionary thinking, because incremental increases (even if they surpass magical milestones) are unlikely to attract the kind of research attention and funding that GBIF could really benefit from.
I’ll leave it to others to weigh in—I’ve got journalists to pitch—but I think ‘visionary thinking’ very much the intention behind GBIC2 later this month.
In related news: Fungi OTUs likely to appear in the backbone next week.
@kcopas Thanks for the link to GBIC2, I’d not seen that before. There’s nothing there that I would describe as visionary or creative as such, it’s much more about process, culture, etc. Important stuff, but not what I’m looking for. I guess I’m looking for the sort of innovation you get from start ups.
Looking forward to seeing what the fungal OTUs look like, will try and remember to take a look next week.
OTUs are up—see starter thread: